NYSE:SOLVMedical Equipment
Solventum (SOLV) Stock Retreats As Tariff Refund Clouds Underlying Growth
Solventum just gave investors a sentiment whiplash. The stock walked into this earnings print with a solid 90 day gain and then dropped about 5% today, even as Q2 landed ahead of expectations with revenue of about US$2.2b and reported earnings per share of US$2.55.
The market is latching onto the noisy pieces of the story, including advanced ERP related orders and a one time tariff refund that padded margins. The real question now is whether this pullback is a reason to doubt the quality of...